Autopsy report · NCT06181227
A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema
Cause of deathFunding or business, also drug or device supply
“The trial was stopped early due to insufficient study drug supply and study funding constraints”
Life of this trial
- Ran for about 4 months before it stopped.
- 21 participants enrolled.
- Results were posted on the registry 1 year 3 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Aviceda Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Diabetic Macular Edema; Diabetic Retinopathy
- Interventions
- AVD-104
- Participants
- 21
- Sites
- 3
- Countries
- United States
Trials that died the same way
- Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias
“Clinical trial was halted prematurely due to low enrollment” - A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
“Trial was terminated to allow sponsors to evaluate the future development of the drug program” - A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
“The trial was terminated early due to regulatory constraints preventing the continuation of study conduct.” - One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
“The study was terminated early due to difficulty in enrollment and lack of clinical study drug access.” - Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies
“Study was terminated early due to lack of experimental medication (supply issues)”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.